Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp220 | Gestational and Type 1 Diabetes | ECE2019

Definition of a third-trimester HbA1c cut-off point for an increased risk of Large-for-Gestational-Age in mothers with Gestational Diabetes

Fonseca Liliana , Duarte Diana Borges , Amado Ana , Lau Eva , Pichel Fernado , Goncalves Joaquim , Pinto Clara , Vilaverde Joana , Dores Jorge , Cardoso Helena

Introduction: Gestational diabetes mellitus (GDM) is associated with important neonatal risks and a higher incidence of large-for-gestational-age (LGA) newborns and fetal macrosomia. The aim of our work was to define a third-trimester HbA1c cut-off point for increased risk of fetal morbidity, macrosomia and LGA newborns.Methodology: Observational retrospective study of all singleton pregnant women with GDM, followed at our Diabetes and Pregnancy Clinic b...

ea0063p919 | Diabetes, Obesity and Metabolism 3 | ECE2019

Diabetes Eruditus: Characteristics of type 1 diabetes of long duration

Duarte Diana Borges , Amaral Claudia , Amado Ana , Teixeira Sofia , Carvalho Andre , Vilaverde Joana , Freitas Claudia , Palma Isabel , Dores Jorge , Carvalho Rui , Bacelar Conceicao , Ramos Helena , Cardoso Helena

Introduction and aim: Type 1 diabetes mellitus (T1DM) presents as a challenge for both health care providers and patients looking to avoid chronic complications and early mortality. Clinical features of patients with long duration T1DM are still poorly studied and debated. The aim of our work was to describe the clinical features of subjects with long duration T1DM.Methods: Cross-sectional study of patients with T1DM with more than 40 years of evolution ...

ea0049gp128 | Endocrine Tumours | ECE2017

Peptides derived from the sst5TMD4 extracellular domain increase malignancy of endocrine-related cancer cells

Gahete Manuel D , Rio-Moreno Mercedes del , Alors-Perez Emilia , de Souza Patricia Borges , Prados-Gonzalez Maria E , Castano Justo P , Luque Raul M

A growing number of studies suggest that extracellular fragments derived from plasma membrane receptors can play relevant functional roles in the development and progression of certain tumoral pathologies which might, therefore, serve as novel tools in the diagnostic and prognostic of such pathologies. In this scenario, the truncated somatostatin receptor sst5TMD4, which is overexpressed in various endocrine-related cancers (i.e. breast, prostate, neuroendocrine, liver and pit...

ea0049gp229 | Thyroid Cancer | ECE2017

Trends in papillary microcarcinoma prevalence in North of Portugal

Pereira Teresa Alves , Amado Ana , Gouveia Patricia , Castro Rosa , da Costa Antonio Moreira , de Carvalho Andre Couto , Freitas Claudia , Borges Fatima

Introduction and Objectives: The incidence of thyroid cancer has increased worldwide. This increase has been attributed to more diagnosed papillary thyroid microcarcinomas. The purpose of this study was to analyse the growing trend of first appointments in our Thyroid Cancer Unit, namely patients with papillary microcarcinomas.Methods: We performed a retrospective study based on the patients diagnosed with thyroid cancer between 1960 and 2016. We divided...

ea0049ep496 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Maturity onset diabetes of the young - clinical characteristics of a portuguese cohort

Amado Ana , Almeida Raquel , Carvalho Andre , Amaral Claudia , Freitas Claudia , Bacelar Conceicao , Vilaverde Joana , Cardoso Maria Helena , Teixeira Sofia , Borges Fatima

Introduction: Maturity onset diabetes of the young (MODY) accounts for 1-2% of all forms of diabetes mellitus (DM). As classic criteria that lead to its suspicion have low sensitivity, patients are often misdiagnosed with type 1 or type 2 DM. Correct classification of this type of diabetes becomes essential for proper management of the disease. Our objective was to describe clinical features of patients with MODY diagnosed at our institution.Methods: We ...

ea0049ep899 | Neuroendocrinology | ECE2017

Endogenous Cushing’s syndrome ( clinical and biochemical features in a large cohort of patients

Vilar Lucio , Vilar Clarice , Albuquerque Jose Luciano , Trovao Erik , The Ana Carolina , Gadelha Patricia , Melo Maira , Gomes Barbara , Borges Thaise , Cardoso Izabela , Lyra Ruy

Patients and methods: We retrospectively analysed the clinical and biochemical characteristics of a cohort of 150 patients with endogenous Cushing’s syndrome (CS). Cushing’s disease (CD) accounted for 61.3% of cases (n=92), ectopic ACTH secretion (EAS) 7.3% (n=11), and adrenal diseases 31.3% (n=47). Among CD cases, there were 19 macroadenomas (20.6%), a female predominance (60.5%) and a median age of 33 years old (range 14–55). Bronchi...

ea0037ep311 | Calcium and Vitamin D metabolism | ECE2015

Primary hyperparathyroidism presented as humeral brown tumor and multiple bone fractures

Ferreira Lia , Gomes Pedro , Cardoso Pedro , Valente Vitor , Amado Ana , Pereira Maria Teresa , Garrido Susana , Almeida Raquel , Freitas Claudia , Amaral Claudia , Palma Isabel , Borges Fatima

Primary hyperparathyroidism (PHPT) is frequently diagnosed as an incidental finding of hypercalcemia. Overt bone disease (osteitis fibrosa cystica or brown tumor), with history of pathologic fractures is a rare presentation.A 48-year-old woman was admitted in with pain in the right thigh after a trivial fall. She also complained of generalized weakness and lethargy over the last 2 years. Her medical history mention multiple bone fractures in the last 6 y...

ea0035p1134 | Thyroid Cancer | ECE2014

Papillary thyroid microcarcinoma: focus on prevalence, characterization and follow-up during a 10 years time period

Pereira Maria Teresa , Carvalho Andre , Garrido Susana , Caldas Ana Rita , Freitas Claudia , Teixeira Sofia , Valente Vitor , Canha Antonio , Costa Moreira , Bateira Paulo , Borges Fatima

Introduction: Recent studies point to an ever increasing papillary thyroid microcarcinoma (PTMC) prevalence, with a percentage range between 20 and 43% of all differentiated thyroid carcinomas. It is many times considered an ‘incidental’ finding and its clinical behaviour is uncertain.Aims: To characterize a cohort of patients with PTMC, with reference to clinical and pathological variables and outcome.Methods: Data from ...

ea0056gp208 | Pituitary Clinical | ECE2018

The role of clomiphene citrate in the resolution of hypogonadism in male patients with prolactinomas under cabergoline therapy

Vilar Lucio , Vilar Clarice , Lyra Ruy , The Ana Carolina , Trovao Erik , Gadelha Patricia , Cardozo Izabela , Borges Thaize , Sampaio Icaro , Ferreira Liana , Albuquerque Luciano

Background: Dopamine agonists (DA) are the treatment of choice of prolactinomas. Cabergoline is preferable to bromocriptine due to its greater effectiveness and better tolerabilitiy. However, up to 30–50% of male patients may persist with low levels of testosterone despite prolactin (PRL) normalization under DA therapy or the use of the maximum tolerated dose of DA. The aim of this prospective open study was to evaluate the efficacy of the SERM clomiphene citrate (CC) in ...

ea0056p888 | Pituitary - Clinical | ECE2018

Lanreotide autogel may be an effective approach for acromegalic patients who failed octreotide lar

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , Trovao Erik , The Ana Carolina , Sampaio Icaro , Ferreira Liana , Cardoso Izabela , Borges Thaise , Aroucha Priscila , Gadelha Patricia , Lyra Ruy

Background: Growth hormone secreting pituitary gland adenomas specifically express somatostatin (SST)-2 and SST5 receptors. First-generation somatostatin analogs (octreotide and lanreotide) are the mainstay in the medical treatment of acromegaly, however the percentage of patients controlled with these drugs significantly varies in the different studies (20–70%). Many factors are involved in the resistance to SRL somatostatin analogs such as sst, AIP, E-cadherin, ZAC1, fi...